Form 8-K - Current report:
SEC Accession No. 0001193125-26-257387
Filing Date
2026-06-04
Accepted
2026-06-04 16:06:40
Documents
11
Period of Report
2026-06-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d162455d8k.htm   iXBRL 8-K 24430
  Complete submission text file 0001193125-26-257387.txt   135557

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA medp-20260601.xsd EX-101.SCH 3164
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE medp-20260601_lab.xml EX-101.LAB 17232
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE medp-20260601_pre.xml EX-101.PRE 10801
14 EXTRACTED XBRL INSTANCE DOCUMENT d162455d8k_htm.xml XML 3487
Mailing Address 5375 MEDPACE WAY CINCINNATI OH 45227
Business Address 5375 MEDPACE WAY CINCINNATI OH 45227 (513) 579-9911
Medpace Holdings, Inc. (Filer) CIK: 0001668397 (see all company filings)

EIN.: 320434904 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37856 | Film No.: 261064941
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)